Carbon copy of a typescript letter. Prof. Macleod writes in regard to the Toronto group's application for a United States patent for insulin and the Eli Lilly & Company's own application, the Rhodehamel, Walden and Scott application. Macleod reminds Mr. Lilly that his company agreed to alter their application.